Drug Screening Market Size, Share, Demand, Trends, Growth and Forecast Analysis

Drug Screening
Drug Screening

Drug screening is examining samples such as urine, breath, oral fluid, hair, and other bodily fluids for the presence of compounds that exceed the legal limit. The importance of drug testing is because a person under the influence of drugs or alcohol is more likely to cause accidents on the road and in the workplace. Drug Screening Market tests are available from companies like Abbott Laboratories for use in the workplace, government agencies, rehabilitation clinics, and other locations. These tests are non-invasive and painless. Furthermore, manufacturers such as Alere, Inc. (part of Abbott Laboratories) offer drug screening point-of-care diagnostic tests.

Additionally, drug addicts in specific professions, such as air traffic controllers and commercial drivers, can jeopardize the safety of others, which can be averted with pre-employment urine testing. Drug testing could also assist to cut down on on-the-job accidents. A urine drug test is painless and looks for prescription drugs such amphetamines, methamphetamines, benzodiazepines, marijuana, barbiturates, cocaine, methadone, and opioids in the pee (narcotics). Furthermore, over the forecast period, technological advances are expected to support the Drug Screening Market Growth. In 2017, Intelligent Fingerprinting Limited, for example, released a non-invasive portable fingerprint drug test.

Furthermore, drug and alcohol treatment facilities must test residents on a regular basis to guarantee that they are sober. Oral fluid testing and breath testing are used to check for the presence of alcohol in the body and to determine its level. The drug screening industry has grown as a result of technological improvements such as immunoassay techniques for drug screening and quick point-of-care diagnostics.

Market Drivers for Drug Screening

The expansion of the Drug Screening Market is being aided by competition among top manufacturers in the industry. Manufacturers are working on new items in a variety of sectors in order to maintain their market leadership. In 2016, Alere, Inc. and its partner firm GenPrime, Inc. released the xReader, a point-of-care testing device for workplace drug testing. Alere, Inc. released the Alere iCup Rx drug screen in 2017 to detect widely mishandled and abused prescription medicines. 

Comments

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Global Report on LED Driver Market for the Forecast Period 2023-2030